Cargando…
Author Correction: Altered kynurenine pathway metabolites in a mouse model of human attention-deficit hyperactivity/autism spectrum disorders: A potential new biological diagnostic marker
Autores principales: | Murakami, Yuki, Imamura, Yukio, Saito, Kuniaki, Sakai, Daisuke, Motoyama, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048848/ https://www.ncbi.nlm.nih.gov/pubmed/32111907 http://dx.doi.org/10.1038/s41598-020-60585-3 |
Ejemplares similares
-
Altered kynurenine pathway metabolites in a mouse model of human attention-deficit hyperactivity/autism spectrum disorders: A potential new biological diagnostic marker
por: Murakami, Yuki, et al.
Publicado: (2019) -
Maternal Inflammation with Elevated Kynurenine Metabolites Is Related to the Risk of Abnormal Brain Development and Behavioral Changes in Autism Spectrum Disorder
por: Murakami, Yuki, et al.
Publicado: (2023) -
Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
por: Oades, Robert D, et al.
Publicado: (2010) -
Author Correction: A randomized-controlled neurofeedback trial in adult attention-deficit/hyperactivity disorder
por: Barth, Beatrix, et al.
Publicado: (2022) -
Author Correction: Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder
por: Demontis, Ditte, et al.
Publicado: (2021)